View More Recent Stories

Apr 9, 2015 12:34PM clypd Raises $19.4 Million in Series B Round Funding to Fuel Development of Programmatic TV Technology
Apr 8, 2015 08:15AM Padlock Therapeutics Initiates Collaborations with Three Leading Research Partners on the Biology of PAD Enzymes
Mar 31, 2015 08:15AM X-Chem and Navitor Pharmaceuticals Enter into License Agreement on Novel Small Molecules Targeting mTORC1 Activation
Mar 26, 2015 02:05PM Form 4 ZAFGEN, INC. For: Mar 24 Filed by: Atlas Venture Associates VII, Inc.
Mar 13, 2015 02:00PM Inmoji Partners With textPlus to Provide Peer-to-Peer Engagement in Mobile Messaging
Feb 12, 2015 02:15PM Form SC 13G Egalet Corp Filed by: Atlas Venture Fund VII L P
Feb 12, 2015 02:14PM Form SC 13G/A Horizon Pharma plc Filed by: ATLAS VENTURE FUND VI LP
Feb 12, 2015 02:13PM Form SC 13G ZAFGEN, INC. Filed by: Atlas Venture Fund VII L P
Feb 12, 2015 02:12PM Form SC 13G Vitae Pharmaceuticals, Filed by: ATLAS VENTURE FUND VI LP
Feb 4, 2015 07:20AM Medicines Co. (MDCO) Completes Annovation Biopharma Acquisition
Nov 28, 2011 06:31AM GSV Capital (GSVC) Increases Facebook Stake; Announces $21M in Investments
Dec 19, 2008 09:20AM Helicos BioSciences (HLCS) Announces $18.6 Million Private Placement
Dyne Therapeutics Appoints David Lubner to Board of Directors
Form 13F-HR Atlas Venture Life Scien For: Jun 30
View More Recent Stories